Literature DB >> 2339835

Pulmonary function measures in healthy infants. Variability and size correction.

J P Hanrahan1, I B Tager, R G Castile, M R Segal, S T Weiss, F E Speizer.   

Abstract

We conducted 151 tests of pulmonary function (PF) on 72 healthy infants younger than 2 yr of age using partial expiratory flow volume (PEFV) maneuvers and helium dilution determination of FRC. After tests were grouped into four strata based on postconception (PC) age, variability and sex differences in level of PF were examined. No significant sex differences were found for any PF measure in any age stratum, even when somatic size was controlled by length correction. Force expiratory flow measures, however, tended to be greater in girls than in boys in the youngest infants. Flow measures demonstrated greater between-subject variability than did volumes, and variability was greatest in the youngest infants. Within-subject variability also was more pronounced for flow measures, particularly in infants younger than 50 PC wk of age. Across the age range of infants studied, all PF measures were related linearly to somatic size as measured by either length, weight, or chest circumference. Length offered the best individual size correction of the three size parameters studied. Linear regression of PF parameters versus length demonstrated FRC to increase at 5.39 ml/cm over this age range, whereas flow at FRC increased by 9.67 ml/s/cm. We conclude that the variability of infant PF measures is greatest in early infancy, that measures of forced expiratory flow are more variable than volume measures, and that sex differences in infant PF do not appear significant. Length is related linearly to PF measures and offers reasonable size correction for healthy infants younger than 18 months of age.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339835     DOI: 10.1164/ajrccm/141.5_Pt_1.1127

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

1.  Repeatability of lung function tests during methacholine challenge in wheezy infants.

Authors:  C Delacourt; M R Benoist; S Waernessyckle; P Rufin; J J Brouard; J de Blic; P Scheinmann
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values.

Authors:  Anastassios C Koumbourlis; Xin C Chen; J Sunil Rao; Mark D Schluchter; Kirk Easley; Andrew A Colin; Peter Hiatt; Meyer Kattan; Kevin McCarthy; Robert B Mellins; Hannah Peavy; Arnold C G Platzker; Suzanne Steinbach; Andrew Ting; Michael D Weisner; Mary Ellen B Wohl
Journal:  Pediatr Pulmonol       Date:  2004-04

3.  Respiratory function of very prematurely born infants at follow up: influence of sex.

Authors:  M R Thomas; L Marston; G F Rafferty; S Calvert; N Marlow; J L Peacock; A Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01-17       Impact factor: 5.747

4.  Respiratory responses to hypoxia/hypercapnia in small for gestational age infants influenced by maternal smoking.

Authors:  B C Galland; B J Taylor; D P G Bolton; R M Sayers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

5.  Efficacy of cromoglycate in persistently wheezing infants.

Authors:  S Furfaro; S Spier; S P Drblik; J P Turgeon; M Robert
Journal:  Arch Dis Child       Date:  1994-10       Impact factor: 3.791

6.  Cardiopulmonary function in premature infants with bronchopulmonary dysplasia--a 2-year follow up.

Authors:  T Farstad; F Brockmeier; D Bratlid
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

7.  Witnessing community violence in residential neighborhoods: a mental health hazard for urban women.

Authors:  Cheryl Clark; Louise Ryan; Ichiro Kawachi; Marina J Canner; Lisa Berkman; Rosalind J Wright
Journal:  J Urban Health       Date:  2007-10-27       Impact factor: 3.671

8.  Lung function from infancy to school age in cystic fibrosis.

Authors:  C S Beardsmore
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

9.  Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis.

Authors:  A J Colom; A M Teper; W M Vollmer; G B Diette
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

Review 10.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.